Evidence map›Paper›PMID 40672482›Full record

ArticlemedRxiv : the preprint server for health sciences2025

The Global Landscape of Genetic Variation in Parkinson's disease: Multi-Ancestry Insights into Established Disease Genes and their Translational Relevance.

Lara M Lange, Zih-Hua Fang, Mary B Makarious, Nicole Kuznetsov, Kajsa Atterling Brolin, Shannon Ballard, Soraya Bardien, Maria Leila Doquenia, Peter Heutink, Henry Houlden and 37 more

Abstract readPreprint
In one paragraph

Article in medRxiv : the preprint server for health sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

47 authors.

Lara M LangeLaboratory of Neurogenetics, National Institute on Aging, Bethesda, Maryland, USA.ORCID 0000-0002-7162-9821
Zih-Hua FangGerman Center for Neurodegenerative Diseases (DZNE), Tu bingen, Germany.ORCID 0000-0002-0225-8772
Mary B MakariousDataTecnica, Washington, DC, USA.ORCID 0000-0002-7978-1051
Nicole KuznetsovDataTecnica, Washington, DC, USA.ORCID 0009-0005-9847-0282
Kajsa Atterling BrolinTranslational Neurogenetics Unit, Department of Experimental Medical Science, Lund University, Lund, Sweden.ORCID 0000-0003-4832-922X
Shannon BallardDataTecnica, Washington, DC, USA.
Soraya BardienDivision of Molecular Biology and Human Genetics, Faculty of Medicine and Health Sciences, Stellenbosch University; South African Medical Research Council/Stellenbosch University Genomics of Brain Disorders Research Unit, Cape Town, South Africa.ORCID 0000-0002-3508-3438
Maria Leila DoqueniaDepartment of Neuroscience and Brain Health, Metropolitan Medical Center, Manila, Philippines.ORCID 0000-0003-3708-6680
Peter HeutinkThe Global Parkinson's Genetics Program (GP2).ORCID 0000-0001-5218-1737
Henry HouldenUniversity College London, Institute of Neurology, Department of Neuromuscular Diseases, Queen Square, WC1N 3BG London, UK.ORCID 0000-0002-2866-7777
Hirotaka IwakiDataTecnica, Washington, DC, USA.ORCID 0000-0002-8982-7885
Simona JasaityteDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.ORCID 0009-0009-6030-2901
Lietsel JonesDataTecnica, Washington, DC, USA.ORCID 0000-0001-5293-0654
Johanna JunkerUniversity Hospital Schleswig Holstein, Campus Luebeck, Luebeck, Germany.ORCID 0000-0003-0756-9569
Rauan KaiyrzhanovUniversity College London, Institute of Neurology, Department of Neuromuscular Diseases, Queen Square, WC1N 3BG London, UK.ORCID 0000-0003-1640-4010
Mathew J KoretskyDataTecnica, Washington, DC, USA.ORCID 0000-0003-4341-3991
Kishore R KumarNeurology Department and Molecular Medicine Laboratory, Concord Repatriation General Hospital and University of Sydney, Concord, NSW, 2139.
Latin American Research Consortium on the Genetics of Parkinson's Disease (LARGE-PD)
Hampton L LeonardDataTecnica, Washington, DC, USA.ORCID 0000-0003-2390-8110
Kristin S LevineDataTecnica, Washington, DC, USA.
Shen-Yang LimDivision of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.ORCID 0000-0002-6942-2522
Niccoló E MencacciDepartment of Neurology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.ORCID 0000-0003-3383-9665
Wael M Y MohamedDepartment of Basic Medical Sciences, Kulliyyah of Medicine, International Islamic University Malaysia (IIUM), Kuantan, Pahang, Malaysia.
Mike A NallsDataTecnica, Washington, DC, USA.
Alastair J NoyceCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.
Rajeev OjhaDepartment of Neurology, Tribhuvan University Teaching Hospital, Kathmandu, Nepal.
Njideka U OkubadejoNeurology Unit, Department of Medicine, College of Medicine, University of Lagos, Lagos State, Nigeria.ORCID 0000-0003-2975-8803
Shoaib Ur RehmanDepartment of Biotechnology, University of science and Technology Bannu, Pakistan.ORCID 0000-0003-2886-9288
Laurel ScrevenThe Global Parkinson's Genetics Program (GP2).ORCID 0000-0002-1330-7779
Chingiz ShashkinInternational Research Institute of Postgraduate Education, Department of Neurosurgery and Neurology, Almaty, Kazakhstan.ORCID 0000-0002-8162-4864
Sophia SopromadzeDepartment of Neurology, Ivane Javakhishvili Tbilisi State University, Tbilisi, Georgia.
Eleanor J StaffordDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0003-2451-4308
Ai Huey TanDivision of Neurology, Department of Medicine, Faculty of Medicine, University of Malaya, Kuala Lumpur, Malaysia.ORCID 0000-0002-2979-3839
Manuela TanCentre for Preventive Neurology, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom.ORCID 0000-0001-5835-669X
Zaruhi TavadyanNational Institute of Health, Yerevan, Armenia.ORCID 0000-0003-2575-7088
Joanne TrinhInstitute of Neurogenetics, University of Luebeck, Luebeck, Germany.
Bayasgalan TserensodnomDepartment of Neurology, School of Medicine, Mongolian National University of Medical Sciences, Ulaanbaatar, Mongolia.ORCID 0009-0009-9929-2034
Enza Maria ValenteDepartment of Molecular Medicine, University of Pavia, Pavia, Italy.ORCID 0000-0002-0600-6820
Dan VitaleDataTecnica, Washington, DC, USA.ORCID 0000-0002-0637-3671
Nazira ZharkinbekovaNeurology Department and Molecular Medicine Laboratory, Concord Repatriation General Hospital and University of Sydney, Concord, NSW, 2139.ORCID 0000-0002-5069-1562
Katja LohmannInstitute of Neurogenetics, University of Luebeck, Luebeck, Germany.
Sara Bandres-CigaCenter for Alzheimer's and Related Dementias (CARD), National Institute on Aging and National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, MD, USA.
Cornelis BlauwendraatThe Global Parkinson's Genetics Program (GP2).ORCID 0000-0001-9358-8111
Andrew SingletonThe Global Parkinson's Genetics Program (GP2).ORCID 0000-0001-5606-700X
Huw R MorrisDepartment of Clinical and Movement Neurosciences, UCL Queen Square Institute of Neurology, London, UK.ORCID 0000-0002-5473-3774
Christine KleinInstitute of Neurogenetics, University of Luebeck, Luebeck, Germany.ORCID 0000-0003-2102-3431
Global Parkinson’s Genetics Program (GP2)

Funding

Genome wide SNP analysis in Parkinson's diseaseZIAAG000949 · NIA · NATIONAL INSTITUTE ON AGING · PI SINGLETON, ANDREW · 2009 to 2024
$12.6M
Understanding the role of BORCS5 in neuronal lysosomal function and neurodegenerationK08NS131581 · NINDS · NORTHWESTERN UNIVERSITY AT CHICAGO · PI Niccolo E Mencacci · 2024 to 2026
$673k
Intramural NIH HHS ZIA AG000949NINDS NIH HHS K08 NS131581Wellcome Trust
6 · The paper itself

Abstract

Background: The genetic architecture of Parkinson's disease (PD) varies considerably across ancestries, yet most genetic studies have focused on individuals of European descent, limiting our insights into the genetic architecture of PD at a global scale. Methods: We conducted a large-scale, multi-ancestry investigation of causal and risk variants in PD-related genes. Using genetic datasets from the Global Parkinson's Genetics Program, we analyzed sequencing and genotyping data from 69,881 individuals, including 41,139 affected and 28,742 unaffected, from eleven different ancestries, including ~30% of individuals from non-European ancestries. Findings: Our findings revealed shared and ancestry-specific patterns in the prevalence and spectrum of PD-associated variants. Overall, ~2% of affected individuals carried a causative variant, with substantial variations across ancestries ranging from <0·5% in African, African-admixed, and Central Asian to >10% in Middle Eastern and Ashkenazi Jewish ancestries. Including disease-associated Interpretation: This large-scale, multi-ancestry assessment offers crucial insights into the population-specific genetic architecture of PD. It underscores the critical need for increased diversity in PD genetic research to improve diagnostic accuracy, enhance our understanding of disease mechanisms across populations, and ensure the equitable development and application of emerging precision therapies.

Indexed as

causal variantsGBA1GeneticsLRRK2Multi-ancestryPDprecision medicinePRKNrisk variantsSNCA

Identifiers

PMID40672482
PMCPMC12265751

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.